05Jun/13

Heart failure guidelines- New hope in medical therapy – Family Practice News Digital Network

Heart failure guidelines- New hope in medical therapy
Family Practice News Digital Network
The newest heart failure management guidelines make a bold statement: Heart failure should no longer be considered a death sentence, but can instead be managed in a way that may add years of quality life for some patients. “With optimal therapy applied
ACC, AHA release guideline for treating heart failureNurse.com
Stingfellow Memorial Hospital receives American Heart Association awardThe Birmingham News – al.com

all 3 news articles »

05Jun/13

FDA Approves Lenalidomide for the Treatment of Mantle Cell Lymphoma – OncLive


Moneycontrol.com

FDA Approves Lenalidomide for the Treatment of Mantle Cell Lymphoma
OncLive
The MCL-001 study enrolled 134 patients with MCL who had received prior treatment with rituximab, cyclophosphamide, an anthracycline (or mitoxantrone), and bortezomib alone or in combination and who had documented relapsed or refractory disease.
Celgene Corporation gets USFDA approves for REVLIMIDMoneycontrol.com
FDA clears Celgene’s sNDA for mantle cell lymphoma drug candidatePharmaceutical Business Review
Revlimid Gains New Lymphoma IndicationMonthly Prescribing Reference

all 17 news articles »